Covid-19 roundup: FDA seeks vaccine adcomm meetings on Dec. 8-10 — report; Hahn to make all EUA data public
With Pfizer releasing its completed Phase III efficacy and safety data Wednesday morning, the FDA is reportedly asking its adcomm to set aside dates in early December to discuss Covid-19 vaccines.
The adcomm will likely convene on Dec. 8, 9 and 10 to go over not only Pfizer’s vaccine candidate, but also Moderna’s, according to a CNBC report. The plans are not yet finalized, per two sources quoted in the story.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.